Drug
Iobenguane I-123 clinical trials
How studies write it
Studies that test it under each name
Other names
Combined with it in one product
Studies by the year they started
7 studies that test it; most in 2005 (3)
| Year | Studies |
|---|---|
| 2005 | 3 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 4
GE Healthcare (4) · University of Maryland, Baltimore (1) · Timothy M. Bateman (1) · Mayo Clinic (1) · Vancouver Coastal Health (1)
Often tested with
Tested in the same studies.
Iobenguane sulfate i-123 (2) · 3-Iodobenzylguanidine (2)
Studies
Open first, then newest update. How each study uses iobenguane I-123 is read from its arms, and is right about nine times in ten.
Testing it · 8
- Imaging With a Radio Tracer to Guide VT AblationsCompletedNot applicableUniversity of Maryland, BaltimoreNCT01250912Written as 123I-metaiodobenzylguanidine
- Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or NeuroblastomaCompletedPhase 3GE HealthcareNCT00126412Written as 123I-mIBG (meta-iodobenzylguanidine)
- Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular DiseaseCompletedPhase 3GE HealthcareNCT00126438Written as 123I-mIBG (meta-iodobenzylguanidine)
- 123-I mIBG (AdreView) Heart-to-Mediastinal (H/M) Ratio and SPECT Imaging on a Small Field of View-High Efficiency Cardiac SPECT SystemCompletedPhase 4Timothy M. BatemanNCT01868841Written as AdreView
- Cardiac Resynchronization and Iodine Meta-Iodobenzylguanidine (MIBG) ImagingTerminatedPhase 1Mayo ClinicNCT01522378Written as 123 iodine metaiodobenzylguanidine
- Meta-Iodobenzylguanidine Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular DiseaseCompletedPhase 3GE HealthcareNCT00126425Written as 123I-mIBG (meta-iodobenzylguanidine)
- Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.CompletedPhase 4GE HealthcareNCT01936649Written as AdreView (Iobenguane I 123 Injection)
- 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine TumorsStatus unknownPhase 3Vancouver Coastal HealthNCT01373736Written as 123I-meta-iodobenzylguanidine
Given in every arm · 2 — iobenguane I-123 is usual care beside what is tested
- Comparative Study of Cardiac Adrenergic Function Explored by I-123-MIBG and CZT Camera (D-SPECT) Versus Anger Camera in Patients With Heart FailureCompletedNot applicableUniversity Hospital, CaenNCT02515812Written as I-123-MIBG
- International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical DeviceTerminatedPhase 3GE HealthcareNCT02656329Written as Iobenguane I -123 Injection
Codes
What other systems call iobenguane I-123 · ClinicalTrials.gg INT017529
- UNII (FDA) P2TH1XYZ84IOBENGUANE I-123Confirmed FDA, Wikidata
- RxNorm 1426748Confirmed FDA, Wikidata
- Wikidata Q27286037iobenguane I-123Confirmed FDA, Wikidata
- NCI Thesaurus C80094Iobenguane I-123One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | P2TH1XYZ84 | IOBENGUANE I-123 | Confirmed FDA, Wikidata |
| RxNorm | 1426748 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27286037 | iobenguane I-123 | Confirmed FDA, Wikidata |
| NCI Thesaurus | C80094 | Iobenguane I-123 | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.